Andrew West, Ph.D., just as many other UAB researchers, seeks awards from the National Institutes of Health to fund new projects and ideas.
“But that is increasingly harder to do in the current economic climate,” says West, Assistant Professor of Neurology. “The backlogged study sections at NIH now demand significant preliminary data to be competitive. That’s why mechanisms like the new Alabama Drug Discovery Alliance (ADDA) are important and exciting.”
Read the full story from the UAB Reporter